Literature DB >> 13372966

On the physiologic disposition of cycloserine in experimental animals.

G M CONZELMAN, R K JONES.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/metabolism

Mesh：

Substances：

Year:  1956        PMID： 13372966     DOI： 10.1164/artpd.1956.74.5.802

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  7 in total

Review 1.  Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.

Authors:  Kelly E Dooley; Carole D Mitnick; Mary Ann DeGroote; Ekwaro Obuku; Vera Belitsky; Carol D Hamilton; Mamodikoe Makhene; Sarita Shah; James C M Brust; Nadza Durakovic; Eric Nuermberger
Journal:  Clin Infect Dis       Date:  2012-05-21       Impact factor: 9.079

2.  Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors.

Authors:  Gaga Kochlamazashvili; Olena Bukalo; Oleg Senkov; Benedikt Salmen; Rita Gerardy-Schahn; Andreas K Engel; Melitta Schachner; Alexander Dityatev
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

3.  Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; K Matthew Lattal; Christopher L Cunningham
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

4.  D-cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry.

Authors:  Magali Millecamps; Maria V Centeno; Hector H Berra; Charles N Rudick; Simona Lavarello; Tatiana Tkatch; A Vania Apkarian
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

5.  D-Cycloserine: Agonist turned antagonist.

Authors:  T H Lanthorn
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

6.  Enhanced fear limits behavioral flexibility in Shank2-deficient mice.

Authors:  Miru Yun; Eunjoon Kim; Min Whan Jung
Journal:  Mol Autism       Date:  2022-10-03       Impact factor: 6.476

7.  Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine.

Authors:  Steven M LeVine; Sheila Tsau
Journal:  Front Pediatr       Date:  2022-01-18       Impact factor: 3.418
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.